GlaxoSmithKline Gets Final EU OK For Alli

GlaxoSmithKline is said to be extremely pleased with this latest approval

Following on from the approval of the European Union health authorities for the weight loss medication Alli, the final rubber stamp required before the drug is permitted to be sold and marketed has been given. GlaxoSmithKline will now be able to sell the weight loss drug Alli without a prescription over the counter in pharmacies. This means that the active ingredient of the weight loss drug Xenical namely orlistat will be available in half dose versions for overweight and obese individuals.

The diet medication Alli has been available in the United States over the counter at pharmacies for over a year now and GlaxoSmithKline said that it has been selling well and has helped a lot of individuals to lose weight. The active ingredient of Alli and Xenical, orlistat, works by stopping some of the fat that you eat being absorbed into the digestive tract which means that it is excreted as waste from your body. GlaxoSmithKline say that around 1/3 of the fat of a normal meal will be taken out of the digestive process by using orlistat.

GlaxoSmithKline is said to be extremely pleased with this latest approval which is an important part of their expansion plans and which will lead on from the success that they have had with Alli in America. They did stress however that the drug Alli was no “magic bullet” and that it required a commitment to eating a healthy low fat diet.

One thing that we have always stressed at Ukmedix News is that those individuals who use Xenical without making a commitment to other parts of their diets do not get positive results with the drug.  Individuals who keep on eating unhealthy when using the Xenical or Alli drugs will find that they suffer from unpleasant side effects such as excess flatulence and stomach cramps.

At Ukmedix News we are concerned that individuals who get hold of Alli without the correct counselling and advice that doctors issue before giving a Xenical prescription will not understand the importance of healthy eating along with the drug. It is hoped that pharmacists who issue the Alli drug will undertake their responsibilities to inform customers that they must also eat correctly and carefully.